UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059714
Receipt number R000068297
Scientific Title The importance of microvascular dysfunction in patients with chronic thromboembolic pulmonary hypertension
Date of disclosure of the study information 2025/11/17
Last modified on 2025/11/10 10:06:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The importance of microvascular dysfunction in patients with chronic thromboembolic pulmonary hypertension

Acronym

Microcascular dysfunction in patients with CTEPH

Scientific Title

The importance of microvascular dysfunction in patients with chronic thromboembolic pulmonary hypertension

Scientific Title:Acronym

Microcascular dysfunction in patients with CTEPH

Region

Japan


Condition

Condition

Chronic thromboembolic pulmonary hypertension

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will observe the degree of pulmonary microvascular dysfunction in CTEPH patients undergoing BPA treatment using a pressure wire and the CoroFlow Cardiovascular System. Since the effectiveness of BPA treatment strategies using this system has been reported in previous studies, the aim of this study is to deepen the understanding of the pathophysiology of pulmonary microvascular dysfunction from the data obtained during BPA treatment using this system. As mentioned above, there is currently no established index for quantifying the degree of pulmonary microcirculation. Using microcirculation indices obtained with a pressure wire and the CoroFlow Cardiovascular System, we aim to establish indicators that contribute to predicting post-BPA exercise tolerance and optimizing the distribution of pulmonary blood flow.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The following measurements will be performed three months after the final BPA: - Right heart catheterization (PAWP, PAP, RVP, RAP, CO, CI)- Exercise stress right heart catheterization (mPAP/CO slope, PAWP/CO slope)

Key secondary outcomes

1. Patient Basic Information: WHO-FC, emPHasis-10
2. Blood Test Results: Improvement in BNP and Nt-ProBNP
3. Imaging Results: Improvement in pulmonary blood flow on chest contrast CT and lung perfusion scintigraphy
4. Physiological Tests: Pulmonary function tests , transthoracic echocardiography, cardiopulmonary exercise test, 6-minute walk test
5. Blood Gas Tests (arterial, venous)
6. BPA Treatment Details (number of sessions, maximum balloon size, amount of contrast agent used, radiation exposure, fluoroscopy time)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed with CTEPH
2. Patients judged eligible for BPA treatment
3. Patients aged 20 years or older at the time of obtaining consent

Key exclusion criteria

None

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tomohiro
Middle name
Last name Yamaguchi

Organization

Osaka Metropolitan University Graduate School of Medicine

Division name

Cardiovascular Medicine

Zip code

545-8585

Address

1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan

TEL

06-6645-3801

Email

tomohiro.y.1987@gmail.com


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Yamaguchi

Organization

Osaka Metropolitan University Graduate School of Medicine

Division name

Cardiovascular Medicine

Zip code

545-8585

Address

1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan

TEL

06-6645-3801

Homepage URL


Email

tomohiro.y.1987@gmail.com


Sponsor or person

Institute

Osaka Metropolitan University

Institute

Department

Personal name

Tomohiro Yamaguchi


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Osaka Metropolitan University Graduate School of Medicine

Address

6th Floor, Abeno Medics, 1-2-7 Asahimachi, Abeno Ward, Osaka City

Tel

06-6645-3456

Email

gr-a-knky-ethics@omu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 27 Day

Date of IRB

2025 Year 10 Month 27 Day

Anticipated trial start date

2025 Year 11 Month 17 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 11 Month 10 Day

Last modified on

2025 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068297